Log In
Print
BCIQ
Print
Print this Print this
 

VY-SOD101

  Manage Alerts
Collapse Summary General Information
Company Voyager Therapeutics Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat monogenic amyotrophic lateral sclerosis (ALS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today